The Patient Journey: Are You Missing Something?

Do you provide clinical care for patients living with or at risk of HIV? If so, you know how important it is to consider their needs beyond the clinic visit.

By: Brady Atherton

The patient journey is not linear. Social stigma, family issues, mental health challenges, financial hardship, and fear of discrimination are only a few obstacles patients may face. When individuals come to your clinic for care, it is often just the first step in a complicated journey to better health. Although accessing your services is a crucial step towards engaging in a patient’s own sexual wellness, keeping them adherent to their medications often presents a separate set of challenges.

Read full story→

5 Steps to Capturing 340B Referral Prescriptions–And Why Covered Entities Should Consider It

by Melissa Opraseuth, PharmD

Referral prescriptions can be an important additional source of 340B funding for covered entities (CEs). However, it wasn’t until recently that referral prescriptions moved out of the “grey area” of 340B and into the mainstream. Just three years ago, most CEs avoided this area due to operational and compliance concerns. Today, many CEs have already added referral prescription capture to their 340B programs or are actively evaluating solutions.

Read full story→

A Recap of the Acentrus Specialty Conference

Advancing Health System Specialty Pharmacy: Acentrus Specialty Conference Shares Leading Practices

Acentrus Specialty hosted its first Acentrus Specialty Conference on January 12-13, 2021, which brought together pharmacists, manufacturers, and suppliers to examine the challenges, opportunities, and best practices in advancing health system specialty pharmacy practice. A pharmacy paradigm shift is under way, as Integrated Delivery Networks (IDNs) are partnering to grow their specialty pharmacy operations.

Read full story→

A Welcome Letter to the 340B Community from Tango340B

by Monte Ruder, Head of Growth at Tango340b

Hello fellow 340B Report readers. As this is our very first publication on this forum, I would like to take a quick moment to briefly introduce my organization, Tango340B. We are a collective of mission-driven professionals, dedicated to serving organizations who provide care to vulnerable patient populations.

Read full story→

Proven Strategies 340B Covered Entities Can Use to Enhance the Specialty Pharmacy Experience for Patients

Delivering an excellent customer experience is crucial for 340B covered entities seeking to differentiate their in-house specialty pharmacy services from those of external specialty pharmacies. As in other industries, providing great service will boost customer satisfaction and loyalty, leading not only to better clinical results but also to stronger financial growth.

Read full story→

Strategies for Achieving the Right Number of 340B Savings

When it comes to 340B compliance, there’s really only one number for total savings that’s right for your organization. In the popular gameshow, The Price Is Right, the objective is to get as close to the right number without going over. It’s not that different for 340B. If you go over the right number, you’re non-compliant. If you’re under the right number, you’re not optimizing your savings. So, the question is, how do you get to that right number of savings that fits your organization?

Read full story→

View From Capitol Hill: An Inside Look at the Latest Developments Shaping the 340B Program

As 340B covered entities continue to feel the financial impact of Medicare Part B reimbursement cuts and drug manufacturer actions that limit access to 340B pricing, a new Administration and new Congress will soon be in place. What will this mean for the future of the 340B program?

Read full story→


Top 10 Issues to Consider in 2021

Jim Jorgenson, CEO, Visante

As 2020 comes to a close, we recognize it has been a year like no other! Dominated by challenges and uncertainty with the pandemic and the economy, and the political landscape overshadowing everything.

Read full story→